CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beximco Pharmaceuticals Plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beximco Pharmaceuticals Plc
19 Dhanmondi R/A, Road No. 7
Phone: +880 258611001p:+880 258611001 DHAKA, 1205  Bangladesh Ticker: BXPHARMABXPHARMA
Business Summary
Beximco Pharmaceuticals Plc, formerly Beximco Pharmaceuticals Limited, is a Bangladesh-based manufacturer and exporter of medicines. The Company manufactures generic pharmaceutical products and active pharmaceutical ingredients (APIs). It offers products in diverse therapeutic categories, which include antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal. Its portfolio of generics encompasses diverse delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, insulins, prefilled syringes, injectables, nebuliser solutions, oral soluble films, and others. The Company also undertakes contract manufacturing for multinational and global generic pharmaceutical companies. Its allergic disorders include Atrizin, Axodin, Bexidal, Curin, Duvent, Momento, and others. Its cardiovascular includes Amdocal, Amdocal Plus, and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20246/30/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Ahmed S.Rahman
Vice Chairman of the Board Ahmed S.Rahman
Chief Financial Officer Mohammad AliNawaz 1/1/2003
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Beximco Pharma API Ltd.
Beximco Pharmaceuticals Limited
BXMPY
5 additional Business Names available in full report.

General Information
Number of Employees: 1,122 (As of 6/30/2024)
Outstanding Shares: 446,112,089 (As of 12/31/2024)
Shareholders: 48,217
Stock Exchange: DSE
Fax Number: +880 258613888


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, November 17, 2025